IN2012DN03182A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03182A
IN2012DN03182A IN3182DEN2012A IN2012DN03182A IN 2012DN03182 A IN2012DN03182 A IN 2012DN03182A IN 3182DEN2012 A IN3182DEN2012 A IN 3182DEN2012A IN 2012DN03182 A IN2012DN03182 A IN 2012DN03182A
Authority
IN
India
Prior art keywords
compounds
disclosed
methods
intermediates
synthesis
Prior art date
Application number
Other languages
English (en)
Inventor
Chakrapani Subramanyam
Travis T Wager
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IN2012DN03182A publication Critical patent/IN2012DN03182A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN3182DEN2012 2009-10-28 2010-10-20 IN2012DN03182A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25550609P 2009-10-28 2009-10-28
PCT/IB2010/054749 WO2011051858A1 (en) 2009-10-28 2010-10-20 Imidazole derivatives as casein kinase inhibitors

Publications (1)

Publication Number Publication Date
IN2012DN03182A true IN2012DN03182A (enrdf_load_stackoverflow) 2015-09-25

Family

ID=43301770

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3182DEN2012 IN2012DN03182A (enrdf_load_stackoverflow) 2009-10-28 2010-10-20

Country Status (22)

Country Link
US (1) US8518944B2 (enrdf_load_stackoverflow)
EP (1) EP2493876B1 (enrdf_load_stackoverflow)
JP (1) JP5784620B2 (enrdf_load_stackoverflow)
KR (1) KR101421852B1 (enrdf_load_stackoverflow)
CN (1) CN102686580B (enrdf_load_stackoverflow)
AR (1) AR078797A1 (enrdf_load_stackoverflow)
AU (1) AU2010311035B2 (enrdf_load_stackoverflow)
CA (1) CA2777632C (enrdf_load_stackoverflow)
DK (1) DK2493876T3 (enrdf_load_stackoverflow)
ES (1) ES2460065T3 (enrdf_load_stackoverflow)
HR (1) HRP20140252T1 (enrdf_load_stackoverflow)
IL (1) IL219190A0 (enrdf_load_stackoverflow)
IN (1) IN2012DN03182A (enrdf_load_stackoverflow)
MX (1) MX2012004997A (enrdf_load_stackoverflow)
PL (1) PL2493876T3 (enrdf_load_stackoverflow)
PT (1) PT2493876E (enrdf_load_stackoverflow)
RS (1) RS53246B (enrdf_load_stackoverflow)
SI (1) SI2493876T1 (enrdf_load_stackoverflow)
TW (1) TW201125864A (enrdf_load_stackoverflow)
UY (1) UY32977A (enrdf_load_stackoverflow)
WO (1) WO2011051858A1 (enrdf_load_stackoverflow)
ZA (1) ZA201202776B (enrdf_load_stackoverflow)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010509919A (ja) 2006-11-15 2010-04-02 マサチューセッツ・アイ・アンド・イア・インファーマリー 内耳細胞の生成
PL2654750T3 (pl) * 2010-12-20 2017-07-31 Pfizer Inc. Nowe skondensowane związki pirydyny jako inhibitory kinazy kazeiny
WO2014039781A1 (en) 2012-09-07 2014-03-13 Massachusetts Eye & Ear Infirmary Treating hearing loss
US9556179B2 (en) 2012-12-21 2017-01-31 Bristol-Myers Squibb Company Substituted imidazoles as casein kinase 1 D/E inhibitors
WO2014192868A1 (ja) * 2013-05-30 2014-12-04 大日本住友製薬株式会社 環状アミノメチルピリミジン誘導体
ES2926931T3 (es) 2014-02-07 2022-10-31 Agency Science Tech & Res Inhibidores de caseína quinasa 1 basados en azoles 2,4,5-tri-sustituidos como inductores de la cardiomiogénesis
WO2016022776A2 (en) 2014-08-06 2016-02-11 Massachusetts Eye And Ear Infirmary Increasing atoh1 life to drive sensorineural hair cell differentiantion
EP3273955B1 (en) 2015-03-23 2025-11-12 Tianli Biotech Pty Ltd Treatment of respiratory diseases
US11185536B2 (en) 2015-12-04 2021-11-30 Massachusetts Eye And Ear Infirmary Treatment of hearing loss by inhibition of casein kinase 1
JP7080173B2 (ja) 2016-01-29 2022-06-03 マサチューセッツ アイ アンド イヤー インファーマリー 内耳支持細胞の拡大および分化ならびにその使用法
JP2020518621A (ja) * 2017-05-03 2020-06-25 ザ ユニヴァーシティー オブ メルボルン 呼吸器疾患の治療のための化合物
US10973820B2 (en) 2017-12-13 2021-04-13 Facio Intellectual Property B.V. Compounds for treatment of diseases related to DUX4 expression
CA3111848A1 (en) * 2018-09-09 2020-03-12 Qanatpharma Ag Use of casein kinase 1 inhibitors for treating vascular diseases
JP7614646B2 (ja) * 2018-11-07 2025-01-16 ティアンリ バイオテック プロプライエタリ リミテッド 呼吸器疾患の処置のための化合物及び組成物
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合
CN115335057A (zh) * 2020-03-27 2022-11-11 北京原基华毅生物科技有限公司 抑制酪蛋白激酶的方法
CN115298183A (zh) * 2020-03-27 2022-11-04 北京原基华毅生物科技有限公司 作为酪蛋白激酶抑制剂的化合物
AR122711A1 (es) * 2020-06-25 2022-09-28 Alchemedicine Inc COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502178A (ja) * 1990-12-31 1994-03-10 藤沢薬品工業株式会社 イミダゾトリアジン誘導体
IL110296A (en) 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
JP2000507558A (ja) * 1996-03-25 2000-06-20 スミスクライン・ビーチャム・コーポレイション Cns損傷についての新規な治療
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
GB0108770D0 (en) * 2001-04-06 2001-05-30 Eisai London Res Lab Ltd Inhibitors
IL159416A0 (en) * 2001-06-18 2004-06-01 Univ Rockefeller Regulation of neuronal function through metabotropic glutamate receptor signaling pathways
EP1747220B1 (en) * 2003-12-11 2009-04-15 Aventis Pharmaceuticals Inc. Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
JO2629B1 (en) * 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
MX2007001077A (es) * 2004-08-19 2007-04-17 Aventis Pharma Inc Derivados de 3-ariltioindol-2-carboxamida y analogos de los mismos como inhibidores de caseina quinasa ie.
US8372851B2 (en) * 2005-10-21 2013-02-12 Exelixis, Inc. Pyrazolo pyrimidines as casein kinase II (CK2) modulators
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
PL2654750T3 (pl) 2010-12-20 2017-07-31 Pfizer Inc. Nowe skondensowane związki pirydyny jako inhibitory kinazy kazeiny

Also Published As

Publication number Publication date
EP2493876A1 (en) 2012-09-05
CA2777632C (en) 2014-02-25
MX2012004997A (es) 2012-06-12
TW201125864A (en) 2011-08-01
JP5784620B2 (ja) 2015-09-24
CA2777632A1 (en) 2011-05-05
IL219190A0 (en) 2012-06-28
KR20120088759A (ko) 2012-08-08
JP2013509392A (ja) 2013-03-14
EP2493876B1 (en) 2014-02-12
ZA201202776B (en) 2013-06-26
HRP20140252T1 (hr) 2014-04-25
AU2010311035A1 (en) 2012-05-03
US20110098272A1 (en) 2011-04-28
AR078797A1 (es) 2011-12-07
DK2493876T3 (en) 2014-03-10
HK1171220A1 (en) 2013-03-22
SI2493876T1 (sl) 2014-04-30
CN102686580B (zh) 2014-09-10
UY32977A (es) 2011-05-31
PT2493876E (pt) 2014-03-20
PL2493876T3 (pl) 2014-06-30
US8518944B2 (en) 2013-08-27
WO2011051858A1 (en) 2011-05-05
CN102686580A (zh) 2012-09-19
RS53246B (sr) 2014-08-29
KR101421852B1 (ko) 2014-07-22
ES2460065T3 (es) 2014-05-13
AU2010311035B2 (en) 2013-05-16

Similar Documents

Publication Publication Date Title
IN2012DN03182A (enrdf_load_stackoverflow)
IN2015DN01119A (enrdf_load_stackoverflow)
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
WO2007135527A3 (en) Benzimidazolyl compounds
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
MX2013005833A (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
UA99787C2 (en) Lactams as beta secretase inhibitors
IN2014MN02598A (enrdf_load_stackoverflow)
NZ608116A (en) Triazine-oxadiazoles
MX2012013274A (es) Novedosos derivados de la pirimidina.
MX2014012695A (es) Derivados de isoindolona.
IN2012DN01233A (enrdf_load_stackoverflow)
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
MX2014000341A (es) Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades.
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
MX342440B (es) Derivados fluorados de aminotriazol.
PH12013500007A1 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
MX2011011083A (es) Compuestos heterociclicos como inhibidores de mek.
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
IN2012DN01292A (enrdf_load_stackoverflow)
MX2013008340A (es) Novedosas 4-amino-n-hidroxi-benzamidas para el tratamiento de cancer.
WO2010121675A3 (en) Thiazolyl-benzimidazoles